New England SIREN Group

Hi everyone! Our fall Neuro Emergencies course will be virtual again this year - we look forward to seeing you there!

Also, last year, we held a European version in Florence, and this year we will be holding it in Copenhagen, Denmark on May 3 and May 4, 2024, in collaboration with Region Sjaelland and the Danish Society of Emergency Medicine.


https://neuroemergencies.hmscme.com/

https://edqualityinstitute.cventevents.com/event/569dc512-17e0-407f-8f40-5b2742dde7e7/summary?RefId=NEUROEMERGENCIES2024

Neurological Emergencies May 2024. Online registration by Cvent Neurological Emergencies. Online registration by Cvent

Our annual Harvard Neurologic Emergencies CME course will be virtual this year, making it easier than ever to join! We have an amazing lineup of speakers, and tons of time for questions, answers, and discussion. Register early and save $$$!!!!

Neurological Emergencies Harvard Medical School CME: Education to Improve Diagnosis of Neurological Symptoms, Rapidly Identify Emergencies, and Optimize Outcomes

Join us for our virtual Neurological Emergencies course February 24-25. Hope to see you there!
https://www.edqualityinstitute.org/neuro-course-details-2021

What is BOOST-3? BOOST-3 is a research study to learn if either of two strategies for monitoring and treating patients with traumatic brain injury in the ICU is more likely to help them get better. To learn more about this study, please visit: boost3trial.org

What is traumatic brain injury? A traumatic brain injury (TBI) occurs when there is a blow or impact to the head that disrupts the normal function of the brain. To learn more, visit the Centers for Disease Control and Prevention (CDC) website here: https://www.cdc.gov/traumaticbraininjury/index.html

Traumatic Brain Injury | Concussion | Traumatic Brain Injury | CDC Injury Center

Want to learn about a study of emergency care in patients with severe traumatic brain injury? Check out the BOOST-3 study website here: https://siren.network/clinical-trials/boost-3

Thanks to all the doctors, nurses, pharmacists, APPs, research coordinators, and especially patients who participated in this amazing trial!

Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial Children, adults, and older adults with established status epilepticus respond similarly to levetiracetam, fosphenytoin, and valproate, with treatment success in approximately half of patients. Any of the three drugs can be considered as a potential first-choice, second-line drug for benzodiazepine-...

What is the best 2nd line treatment for Status Epilepticus (prolonged, refractory seizures) for children and adults? Come read about it here:

Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial Children, adults, and older adults with established status epilepticus respond similarly to levetiracetam, fosphenytoin, and valproate, with treatment success in approximately half of patients. Any of the three drugs can be considered as a potential first-choice, second-line drug for benzodiazepine-...

Want to learn more about Emergency Research? Click on this short video to learn more!

Emergency Research Q/A This is "Emergency Research Q/A" by Joy Black on Vimeo, the home for high quality videos and the people who love them.

Check out an article on a seizure study we completed showing that three medicines commonly used to treat prolonged seizures all work similarly well here: https://www.massgeneral.org/research/news/articles/esett-trial

Head-to-head comparison finds three anti-seizure drugs equally effective for severe form of epilepsy NIH-funded research shows no difference in efficacy or adverse effects of commonly used treatments.